CSIMarket


Lexaria Bioscience Corp   (LEXX)
Other Ticker:  
 


 

Lexaria Bioscience Corp

LEXX's Financial Statements and Analysis



Lexaria Bioscience Corp increased III. Quarter net loss per share of $-0.50 compare to net loss per share of $-0.02 recorded in the same quarter a year ago a decrease from $0.09 eps realized in II. Quarter (Feb 28 2021).


III. Quarter
Earnings Per Share Revenues
$ -0.5 $  0 Mill
$-0.48     Unch.     +127.58 %



Lexaria Bioscience 's Revenue rose by 127.58 % in III. Quarter (May 31 2021) year on year, to $0 million and advanced by 5.88 % sequentially.


Lexaria Bioscience is Expected to report next financial results on July 14, 2022.

More on LEXX's Income Statement



Lexaria Bioscience 's in III. Quarter recorded net loss of $-3 million, an increase from net loss of $-1 million in III. Quarter a year ago.

Sequentially company realized net loss, compare to net income of $0.42 million in previous quarter.

More on LEXX's Growth

Inventories declined by -61.08 % to $0.05 million from III. Quarter a year ago, sequentially inventories fell by -62.31 %. In III. Quarter company's net cash and cash equivalents decreased by $-1 million, capital expenditures fell by 394.73%, to $-0 millions compare to same quarter a year ago and fell by 2,264.66% from II. Quarter (Feb 28 2021).

More on LEXX's Cash flow Statement


Lexaria Bioscience Corp does not pay out common stock dividend.

In trailing twelve-month period Lexaria Bioscience Corp payed $ -0.70 cash per share, on a free-cash flow basis .

Book value fell by -29.82 % sequentially to $2.03 per share, -130.89% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 2.03 per share from $ 2.89.

Company issued 1.05 million shares or 25.94 % in III. Quarter.


More on LEXX's Dividends

 Market Capitalization (Millions) 34
 Shares Outstanding (Millions) 5
 Total Debt (Millions $) 0
 Revenue (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) -3
 Cash Flow (TTM) (Millions $) 6
 Capital Exp. (TTM) (Millions $) -0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Lexaria Bioscience Corp does not pay out common stock dividend.

In trailing twelve-month period Lexaria Bioscience Corp payed $ -0.70 cash per share, on a free-cash flow basis .

Book value fell by -29.82 % sequentially to $2.03 per share, -130.89% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 2.03 per share from $ 2.89.

Company issued 1.05 million shares or 25.94 % in III. Quarter.


More on LEXX's Balance Sheets

 Market Capitalization (Millions) 34
 Shares Outstanding (Millions) 5
 Total Debt (Millions $) 0
 Revenue (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) -3
 Cash Flow (TTM) (Millions $) 6
 Capital Exp. (TTM) (Millions $) -0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -


   



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BBW's Profile

Stock Price

BBW's Financials

Business Description

Fundamentals

Charts & Quotes

BBW's News

Suppliers

BBW's Competitors

Customers & Markets

Economic Indicators

BBW's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071